Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin)

被引：38

作者：

McNeil, SA

Clark, NM

Chandrasekar, PH

Kauffman, CA

机构：

[1] Univ Michigan, Sch Med, Vet Affairs Healthcare Syst, Div Infect Dis,Dept Internal Med, Ann Arbor, MI 48105 USA

[2] Wayne State Univ, Med Ctr, Dept Internal Med, Div Infect Dis, Detroit, MI 48202 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2000年 / 30卷 / 02期

关键词：

D O I：

10.1086/313669

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：403 / 404

页数：2

共 9 条

[1] Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations [J].

Aeschlimann, JR ;

Zervos, MJ ;

Rybak, MJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2710-2717

[2] Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium [J].

Bonilla, HF ;

Perri, MB ;

Kauffman, CA ;

Zervos, MJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 25 (03) :127-131

[3] Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci [J].

Bostic, GD ;

Perri, MB ;

Thal, LA ;

Zervos, MJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) :109-112

[4] In vitro activities of new oxazolidinone antimicrobial agents against enterococci [J].

Eliopoulos, GM ;

Wennersten, CB ;

Gold, HS ;

Moellering, RC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1745-1747

[5] Antibacterial activity of quinupristin dalfopristin - Rationale for clinical use [J].

Finch, RG .

DRUGS, 1996, 51 :31-37

[6] Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to Enterococci with VanA/VanB resistance patterns [J].

Furlong, WB ;

Rakowski, TA .

CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) :163-164

[7] Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin [J].

Noskin, GA ;

Siddiqui, F ;

Stosor, V ;

Kruzynski, J ;

Peterson, LR .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) :689-690

[8] Vancomycin-resistant enterococci: Clinical, microbiologic, and epidemiologic features [J].

Noskin, GA .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (01) :14-20

[9] Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium [J].

Rybak, MJ ;

Cappelletty, DM ;

Moldovan, T ;

Aeschlimann, JR ;

Kaatz, GW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :721-724

← 1 →